COVID-19 in persons with multiple sclerosis treated with ocrelizumab - A pharmacovigilance case series

被引：49
|
作者：
Hughes, Richard [1 ]
Pedotti, Rosetta [1 ]
Koendgen, Harold [1 ]
机构：
[1] F Hoffmann La Roche Ltd, Basel, Switzerland
来源：
MULTIPLE SCLEROSIS AND RELATED DISORDERS | 2020年 / 42卷
关键词：
D O I：
10.1016/j.msard.2020.102192
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Multiple sclerosis and COVID-19
    Mares, Jan
    Hartung, Hans-Peter
    BIOMEDICAL PAPERS-OLOMOUC, 2020, 164 (03): : 217 - 225
  • [32] Case Report: Exacerbation of Relapses Following mRNA COVID-19 Vaccination in Multiple Sclerosis: A Case Series
    Quintanilla-Bordas, Carlos
    Gascon-Gimenez, Francisco
    Alcala, Carmen
    Paya, Maria
    Mallada, Javier
    Silla, Raquel
    Carratala-Bosca, Sara
    Gasque-Rubio, Raquel
    Castillo, Jessica
    Casanova, Bonaventura
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [33] COVID-19 in teriflunomide-treated patients with multiple sclerosis: A case report and literature review
    Capone, Fioravante
    Motolese, Francesco
    Luce, Tiziano
    Rossi, Mariagrazia
    Magliozzi, Alessandro
    Di Lazzaro, Vincenzo
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 48
  • [34] COVID-19 Vaccine Response in People with Multiple Sclerosis Treated with Dimethyl Fumarate, Diroximel Fumarate, Natalizumab, Ocrelizumab, or Interferon Beta Therapy
    Jaber, Aliya
    Patel, Meera
    Sylvester, Andrew
    Yarussi, Mary
    Kalina, J. Tamar
    Mendoza, Jason P.
    Avila, Robin L.
    Tremblay, Matthew A.
    NEUROLOGY AND THERAPY, 2023, 12 (02) : 687 - 700
  • [35] COVID-19 Vaccine Response in People with Multiple Sclerosis Treated with Dimethyl Fumarate, Diroximel Fumarate, Natalizumab, Ocrelizumab, or Interferon Beta Therapy
    Aliya Jaber
    Meera Patel
    Andrew Sylvester
    Mary Yarussi
    J. Tamar Kalina
    Jason P. Mendoza
    Robin L. Avila
    Matthew A. Tremblay
    Neurology and Therapy, 2023, 12 : 687 - 700
  • [36] The Psychological Impact of COVID-19 Pandemic on Persons with Multiple Sclerosis in Saudi Arabia
    Alshammari, Ahmed N.
    Alshammari, Khalid A.
    Alshammari, Salman N.
    Aldhaifi, Saad Y.
    Alqahtani, Abdulaziz S.
    NEUROSCIENCES, 2023, 28 (02) : 108 - 115
  • [37] COVID-19 in patients with multiple sclerosis treated with cladribine tablets: An update
    Jack, Dominic
    Damian, Doris
    Nolting, Axel
    Galazka, Andrew
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 51
  • [38] COVID-19 in dimethyl fumarate-treated patients with multiple sclerosis
    Mantero, Vittorio
    Abate, Lucia
    Basilico, Paola
    Balgera, Roberto
    Salmaggi, Andrea
    Nourbakhsh, Bardia
    Cordano, Christian
    JOURNAL OF NEUROLOGY, 2021, 268 (06) : 2023 - 2025
  • [39] Familial Mediterranean Fever and multiple sclerosis treated with ocrelizumab: Case report
    Manzano, Giovanna S.
    Rice, Dylan R.
    Zurawski, Jonathan
    Jalkh, Youmna
    Bakshi, Rohit
    Mateen, Farrah J.
    JOURNAL OF NEUROIMMUNOLOGY, 2023, 379
  • [40] Influence of delaying ocrelizumab dosing in multiple sclerosis due to COVID-19 pandemics on clinical and laboratory effectiveness
    Barun, Barbara
    Gabelic, Tereza
    Adamec, Ivan
    Babic, Antonija
    Lalic, Hrvoje
    Batinic, Drago
    Skoric, Magdalena Krbot
    Habek, Mario
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 48
12345